Alzheimer's & Dementia
Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease
Trial in peopleBiomarkers
The paper
The Catholic University of Korea Seoul St. Mary's Hospital
Alzheimer's & Dementia, 7 Sep 2026
